NCT05973539

Brief Summary

The macronutrient composition of a diet (proportions of carbohydrates, fats and proteins) strongly influences the way the body stores and utilises substrates (e.g., fats and sugars), which in turn influences the risk of developing cardiometabolic diseases (e.g., coronary artery disease or insulin resistance). The optimal dietary composition to lower the risk of cardiometabolic disease is unknown. In a randomized, parallel design, this study will investigate how the overconsumption of carbohydrates and fats affects blood lipid responses and liver metabolism in adults free from metabolic disease. By genotyping participants, the interaction between macronutrient content and an individual's genes on blood lipid responses and liver metabolism will be examined.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Feb 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Feb 2023Jan 2028

First Submitted

Initial submission to the registry

January 9, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

February 15, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 3, 2023

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

4.9 years

First QC Date

January 9, 2023

Last Update Submit

May 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in plasma triglyceride concentrations [mmol/L]

    Change in plasma triglyceride concentrations in response to consumption of macronutrient meal will be measured by basic clinical chemistry before and at the end of the dietary intervention.

    Pre- and post-diet [21-28 days]

Secondary Outcomes (5)

  • Change in liver fat content [%]

    Pre- and post-diet [21-28 days]

  • Change in cardiac fat content [%]

    Pre- and post-diet [21-28 days]

  • Change in the contribution of dietary and adipose tissue derived fatty acids to very low density lipoprotein-triglyceride (VLDL-TG) palmitate

    Pre- and post-diet [21-28 days]

  • Change in hepatic fatty acid synthesis

    Pre- and post-diet [21-28 days]

  • Influence of genotype on the change in plasma lipid content [mmol/L]

    Pre- and post-diet [21-28 days]

Study Arms (2)

High carbohydrate, low fat diet

EXPERIMENTAL

65% of energy is derived from carbohydrates, 20% from fat, and 15% from protein.

Other: Diet

High fat, low carbohydrate diet

EXPERIMENTAL

65% of energy is derived from fat, 20% from carbohydrates, and 15% from protein.

Other: Diet

Interventions

DietOTHER

Eucaloric diet enriched in either carbohydrates or fat (both contributing to 65% total energy intake)

High carbohydrate, low fat dietHigh fat, low carbohydrate diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged ≥18 to ≤65 years
  • Body mass index (BMI) ≥19 to ≤35 kg/m2
  • No medical condition or relevant drug therapy that is known to affect the liver, adipose tissue, or cardiac metabolism.
  • Weight stable for the previous 3 months

You may not qualify if:

  • Aged \<18 or \>65 years
  • BMI \<19 or \>35 kg/m2
  • A blood haemoglobin \<135 mg/dL for men and \<120 mg/dL for women
  • Donated (or lost) ≥250 mL of blood in the previous two months
  • On a weight loss diet or decreased their body weight by \>5% in the previous 3 months
  • Currently adhering to or have consumed in the previous 3 months a diet with a notably altered macro-nutrient content (e.g. high-fat - low-carbohydrate diet)
  • Have increased their body weight by \>5% in the previous 3 months
  • Any metabolic condition or relevant drug therapy
  • Current smoker
  • History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women)
  • History of albumin allergy.
  • Pregnant or nursing mothers
  • History of severe claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford

Oxford, OX3 7LE, United Kingdom

RECRUITING

Oxford Centre for Diabetes, Endocrinology and Metabolism

Oxford, OX3 7LE, United Kingdom

RECRUITING

MeSH Terms

Conditions

Nutritional and Metabolic Diseases

Interventions

Diet

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Leane Hodson

    University of Oxford

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 9, 2023

First Posted

August 3, 2023

Study Start

February 15, 2023

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

There are no plans to share IPD with other researchers

Locations